LU92035I2
Pyrrolo [2,3-b]pyridine derivatives as protein kinase inhibitors
Abstract
Compounds active on protein kinases are described, as well as methods of using such compounds to treat diseases and conditions associated with aberrant activity of protein kinases.
Term
5.8 yearsto projected expiry
Projected expiry 28 June 2032, counted from filing; an application has no term until it is granted.
- Priority
- Filed
- Published
- Today
- Projected expiry
123 members in 36 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 69296005 | United States of America | P | |
| 73152805 | United States of America | P | |
| 2006024524 | United States of America | W |
Members123
| Document | Office | Kind | |
|---|---|---|---|
| AU2006261993A1 | Australia | A1 | |
| CA2613015A1 | Canada | A1 | |
| WO2007002325A1 | World Intellectual Property Organization (WIPO) | A1 | |
| WO2007002433A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2006272951A1 | Australia | A1 | |
| CA2608733A1 | Canada | A1 | |
| WO2007013896A2 | World Intellectual Property Organization (WIPO) | A2 | |
| US2007032519A1 | United States of America | A1 | |
| PE20070100A1 | Peru | A1 | |
| WO2007013896A3 | World Intellectual Property Organization (WIPO) | A3 | |
| AR054624A1 | Argentina | A1 | |
| TW200804370A | Taiwan Province of China | A | |
| ECSP077985A | Ecuador | A | |
| MX2007014377A | Mexico | A | |
| EP1885723A2 | European Patent Office (EPO) | A2 | |
| NO20075992L | Norway | L | |
| ECSP088121A | Ecuador | A | |
| MX2007016463A | Mexico | A | |
| EP1893612A1 | European Patent Office (EPO) | A1 | |
| NO20076659L | Norway | L | |
| CR9591A | Costa Rica | A | |
| CR9677A | Costa Rica | A | |
| KR20080027775A | Republic of Korea | A | |
| KR20080030619A | Republic of Korea | A | |
| IL187344A0 | Israel | A0 | |
| IL188248A0 | Israel | A0 | |
| MA29612B1 | Morocco | B1 | |
| CN101223169A | China | A | |
| CN101243084A | China | A | |
| HK1114610A | Hong Kong, China | A | |
| HK1114610A1 | Hong Kong, China | A1 | |
| ZA200709919B | South Africa | B | |
| BRPI0611863A2 | Brazil | A2 | |
| JP2008545652A | Japan | A | |
| JP2008546797A | Japan | A | |
| RU2007142326A | Russian Federation | A | |
| RU2008100933A | Russian Federation | A | |
| NZ565255A | New Zealand | A | |
| BRPI0610066A2 | Brazil | A2 | |
| US2010249118A1 | United States of America | A1 | |
| US2010256365A1 | United States of America | A1 | |
| US7846941B2 | United States of America | B2 | |
| US7863288B2 | United States of America | B2 | |
| UA93679C2 | Ukraine | C2 | |
| US2011059963A1 | United States of America | A1 | |
| NZ563444A | New Zealand | A | |
| RU2418800C2 | Russian Federation | C2 | |
| US2011166174A1 | United States of America | A1 | |
| UA95244C2 | Ukraine | C2 | |
| EP1893612B1 | European Patent Office (EPO) | B1 | |
| AT518860T | Austria | T | |
| ATE518860T1 | Austria | T1 | |
| CN102206216A | China | A | |
| AR078519A2 | Argentina | A2 | |
| AU2006261993B2 | Australia | B2 | |
| DK1893612T3 | Denmark | T3 | |
| PT1893612E | Portugal | E | |
| EP2395004A2 | European Patent Office (EPO) | A2 | |
| ES2371397T3 | Spain | T3 | |
| US2012022098A1 | United States of America | A1 | |
| PL1893612T3 | Poland | T3 | |
| US2012053177A1 | United States of America | A1 | |
| CN101243084B | China | B | |
| AU2012200933A1 | Australia | A1 | |
| US8143271B2 | United States of America | B2 | |
| SI1893612T1 | Slovenia | T1 | |
| CA2613015C | Canada | C | |
| EP2395004A3 | European Patent Office (EPO) | A3 | |
| IL188248A | Israel | A | |
| RS52010B | Serbia | B | |
| KR101125919B1 | Republic of Korea | B1 | |
| ZA200711152B | South Africa | B | |
| RU2011101140A | Russian Federation | A | |
| CN102603581A | China | A | |
| JP5007304B2 | Japan | B2 | |
| LU92035I2This record | Luxembourg | I2 | |
| DE122012000043I1 | Germany | I1 | |
| HK1164866A | Hong Kong, China | A | |
| HK1164866A1 | Hong Kong, China | A1 | |
| ZA201202026B | South Africa | B | |
| MY147410A | Malaysia | A | |
| US8415469B2 | United States of America | B2 | |
| US8470818B2 | United States of America | B2 | |
| CR20130216A | Costa Rica | A | |
| US2013261117A1 | United States of America | A1 | |
| NO333913B1 | Norway | B1 | |
| US2013303534A1 | United States of America | A1 | |
| TW201345906A | Taiwan Province of China | A | |
| NO2014006I2 | Norway | I2 | |
| TWI432193B | Taiwan Province of China | B | |
| NO2014006I1 | Norway | I1 | |
| RU2012150759A | Russian Federation | A | |
| CN102206216B | China | B | |
| TWI473808B | Taiwan Province of China | B | |
| MY153898A | Malaysia | A | |
| TW201514140A | Taiwan Province of China | A | |
| AU2012200933B2 | Australia | B2 | |
| CN102603581B | China | B | |
| CY1111996T1 | Cyprus | T1 | |
| CY2012021I1 | Cyprus | I1 |
Showing 100 of 123
Numbers
- Application
- 92035
Titles2
- English
- Vemurafenib and the pharmaceutically acceptable salts thereof, in any form benefiting from the protection conferred by the basic patent
- French
- Vemurafenib et les sels pharmaceutiquement acceptables de celui-ci, sous toutes les formes bénéficiant de la protection conférée par le brevet de base
Classification
- CPC, 55
- C07D471/04
- A61K31/437
- A61K31/496
- A61K31/5377
- A61P1/00
- A61P1/04
- A61P1/16
- A61P1/18
- A61P11/00
- A61P11/06
- A61P13/08
- A61P13/12
- A61P15/08
- A61P17/00
- A61P17/02
- A61P17/06
- A61P19/02
- A61P19/10
- A61P21/04
- A61P25/00
- A61P25/06
- A61P25/14
- A61P25/16
- A61P25/28
- A61P27/02
- A61P27/16
- A61P29/00
- A61P3/04
- A61P3/14
- A61P31/04
- A61P31/16
- A61P35/00
- A61P35/02
- A61P3/06
- A61P37/00
- A61P37/02
- A61P37/06
- A61P37/08
- A61P43/00
- A61P7/00
- A61P7/02
- A61P9/00
- A61P9/04
- A61P9/10
- A61P3/10
- A61K31/435
- A61K31/416
- C07C37/62
- C07C45/00
- C07C45/673
- C07C45/71
- C07C47/565
- C07C47/575
- C07D209/08
- C07C39/27